Pregled bibliografske jedinice broj: 1056392
Role of platelet gene polymorphisms in ischemic pediatric stroke subtypes: a case-control study.
Role of platelet gene polymorphisms in ischemic pediatric stroke subtypes: a case-control study. // Croatian medical journal, 61 (2020), 1; 18-27 doi:10.3325/cmj.2020.61.18 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1056392 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Role of platelet gene polymorphisms in ischemic
pediatric stroke subtypes: a case-control study.
Autori
Čeri, Andrea ; Leniček Krleža, Jasna ; Coen Herak, Desiree ; Miloš, Marija ; Pavić, Marina ; Barišić, Nina ; Đuranović, Vlasta ; Zadro, Renata
Izvornik
Croatian medical journal (0353-9504) 61
(2020), 1;
18-27
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
platelet gene ; polymorphisms ; ischemic stroke ; children
Sažetak
Aim To assess the role of human platelet antigens (HPA), P-selectin gene (SELP) polymorphisms, and HPA and SELP haplotypes with factor V (FV) R506Q in ischemic pediatric stroke (IPS) subtypes: cerebral sinovenous thrombosis (CSVT), perinatal (PAIS), and childhood (CAIS) arterial ischemic stroke. Methods This case-control study enrolled 150 children with confirmed IPS and 150 age- and sex-matched controls. FV R506Q and HPA-1 were genotyped with CVD StripAssay®, HPA-2 and HPA-3 with real-time polymerase chain reaction, SELP S290N, V599L, and T715P with high resolution melting analysis, and SELP N562D with sequence- specific polymerase chain reaction. Results HPA-1b allele (odds ratio [OR] 2.75, 95% confidence interval [CI] 1.02-7.42, P = 0.048) and HPA-1a2a3b (OR 5.46, 95% CI 1.51-19.76, P = 0.011), HPA- 1b2a3a (OR 7.00, 95% CI 1.25-39.13, P = 0.028), and HPA-1b2b3a (OR 11.39, 95% CI 1.39-92.95, P = 0.024) haplotypes increased the risk for CSVT. HPA-3b allele was significantly associated with 2- fold lower risk for PAIS (OR 0.49, 95% CI 0.26- 0.89, P = 0.020) and CAIS (OR 0.47, 95% CI 0.26- 0.86, P = 0.014) and non- significantly associated with increased risk for CSVT (OR 6.43, 95% CI 0.83-50.00, P = 0.022). HPA-1a2b3a haplotype was significantly associated with CAIS (OR 6.76, 95% CI 2.13- 21.44, P = 0.001). The inclusion of FV R506Q in SELP haplotype analysis increased the risk for PAIS 4-fold in QNDVT carriers (OR 8.14, 95% CI 0.93-71.33, P = 0.060) compared with NDVT haplotype (OR 2.45, 95% CI 0.98-6.18, P = 0.058), but the result was not significant. Conclusion Individual HPAs, and particularly HPA haplotypes, are involved in IPS subtypes pathogenesis. A possible risk-inducing synergistic effect of SELP haplotypes with FV R506Q is restricted to PAIS only.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
IP-2014-09-2047 - Genski polimorfizmi i ishemijski moždani udar u djece (GENESTROKE) (HRZZ - 2014-09) ( CroRIS)
Profili:
Nina Barišić
(autor)
Renata Zadro
(autor)
Desiree Coen Herak
(autor)
Marija Miloš
(autor)
Andrea Čeri
(autor)
Vlasta Đuranović
(autor)
Marina Pavić
(autor)
Jasna Leniček Krleža
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE